Cutaneous manifestations associated with SARS CoV-2: an emerging topic in a pandemic era

Detalhes bibliográficos
Autor(a) principal: Luís, Helena
Data de Publicação: 2021
Outros Autores: Barros, Carolina, Malheiro, Alexandra
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.26/37860
Resumo: A 70-year-old man was admitted to our COVID-19 ward with thoracalgia, productive mucus cough, fatigue and erythematous–violaceous macules on the inner side of feet and interdigital regions. The patient was started on oxygen and dexamethasone. On the day of discharge, he maintained the skin changes despite the resolution of COVID-19 symptoms. A 57-year-old woman initially presented with diffuse urticarial rash on the cervical and chest region. Oral cetirizine was started, and pruritus improved. Thirty days after the discharge, the patient maintained the rash, but without pruritus. A 49-year old man was admitted with thoracalgia, shortness of breath, dry cough and urticarial rash on the cervical and chest region. The patient was treated with cetirizine. The pruritus improved, and 5 days after discharge, the urticarial areas completely disappeared
id RCAP_ec5fdb2e3a935a3478f7fdcb5343e9fd
oai_identifier_str oai:comum.rcaap.pt:10400.26/37860
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Cutaneous manifestations associated with SARS CoV-2: an emerging topic in a pandemic eraCutaneous manifestations associated with SARS CoVID-2SARS-COV-2rashCOVID-19cetirizine.Madeira IslandRegião Autónoma da MadeiraPortugalA 70-year-old man was admitted to our COVID-19 ward with thoracalgia, productive mucus cough, fatigue and erythematous–violaceous macules on the inner side of feet and interdigital regions. The patient was started on oxygen and dexamethasone. On the day of discharge, he maintained the skin changes despite the resolution of COVID-19 symptoms. A 57-year-old woman initially presented with diffuse urticarial rash on the cervical and chest region. Oral cetirizine was started, and pruritus improved. Thirty days after the discharge, the patient maintained the rash, but without pruritus. A 49-year old man was admitted with thoracalgia, shortness of breath, dry cough and urticarial rash on the cervical and chest region. The patient was treated with cetirizine. The pruritus improved, and 5 days after discharge, the urticarial areas completely disappearedBMJ Publishing GroupRepositório ComumLuís, HelenaBarros, CarolinaMalheiro, Alexandra2021-10-29T18:04:12Z2021-07-202021-07-20T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.26/37860engLuís H, Barros C, André D, et al. BMJ Case Rep 2021;14:e244763. doi:10.1136/bcr-2021- 2447631757-790x (online)10.1136/bcr-2021- 244763info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-10T02:18:33Zoai:comum.rcaap.pt:10400.26/37860Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T22:34:35.183750Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Cutaneous manifestations associated with SARS CoV-2: an emerging topic in a pandemic era
title Cutaneous manifestations associated with SARS CoV-2: an emerging topic in a pandemic era
spellingShingle Cutaneous manifestations associated with SARS CoV-2: an emerging topic in a pandemic era
Luís, Helena
Cutaneous manifestations associated with SARS CoVID-2
SARS-COV-2
rash
COVID-19
cetirizine.
Madeira Island
Região Autónoma da Madeira
Portugal
title_short Cutaneous manifestations associated with SARS CoV-2: an emerging topic in a pandemic era
title_full Cutaneous manifestations associated with SARS CoV-2: an emerging topic in a pandemic era
title_fullStr Cutaneous manifestations associated with SARS CoV-2: an emerging topic in a pandemic era
title_full_unstemmed Cutaneous manifestations associated with SARS CoV-2: an emerging topic in a pandemic era
title_sort Cutaneous manifestations associated with SARS CoV-2: an emerging topic in a pandemic era
author Luís, Helena
author_facet Luís, Helena
Barros, Carolina
Malheiro, Alexandra
author_role author
author2 Barros, Carolina
Malheiro, Alexandra
author2_role author
author
dc.contributor.none.fl_str_mv Repositório Comum
dc.contributor.author.fl_str_mv Luís, Helena
Barros, Carolina
Malheiro, Alexandra
dc.subject.por.fl_str_mv Cutaneous manifestations associated with SARS CoVID-2
SARS-COV-2
rash
COVID-19
cetirizine.
Madeira Island
Região Autónoma da Madeira
Portugal
topic Cutaneous manifestations associated with SARS CoVID-2
SARS-COV-2
rash
COVID-19
cetirizine.
Madeira Island
Região Autónoma da Madeira
Portugal
description A 70-year-old man was admitted to our COVID-19 ward with thoracalgia, productive mucus cough, fatigue and erythematous–violaceous macules on the inner side of feet and interdigital regions. The patient was started on oxygen and dexamethasone. On the day of discharge, he maintained the skin changes despite the resolution of COVID-19 symptoms. A 57-year-old woman initially presented with diffuse urticarial rash on the cervical and chest region. Oral cetirizine was started, and pruritus improved. Thirty days after the discharge, the patient maintained the rash, but without pruritus. A 49-year old man was admitted with thoracalgia, shortness of breath, dry cough and urticarial rash on the cervical and chest region. The patient was treated with cetirizine. The pruritus improved, and 5 days after discharge, the urticarial areas completely disappeared
publishDate 2021
dc.date.none.fl_str_mv 2021-10-29T18:04:12Z
2021-07-20
2021-07-20T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.26/37860
url http://hdl.handle.net/10400.26/37860
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Luís H, Barros C, André D, et al. BMJ Case Rep 2021;14:e244763. doi:10.1136/bcr-2021- 244763
1757-790x (online)
10.1136/bcr-2021- 244763
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv BMJ Publishing Group
publisher.none.fl_str_mv BMJ Publishing Group
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134907894595584

Registros relacionados